我国静脉用药集中调配中心收费现状的系统评价(1)
中圖分类号 R952 文献标志码 A 文章编号 1001-0408(2019)17-2414-05
DOI 10.6039/j.issn.1001-0408.2019.17.22
摘 要 目的：系统评价我国静脉用药集中调配中心(PIVAS)收费现状，为我国PIVAS收费标准的制订提供参考。方法：计算机检索PubMed、Embase、Cochrane图书馆、中国生物医学文献数据库、中国知网、维普网和万方数据及相关政府网站，收集自建库起至 2019年1月上述数据库及网站收录的评价我国PIVAS收费现状的文献，收集PIVAS收费的成本测算、收费标准、影响因素等指标，并对结果进行描述性分析。结果：共纳入5篇文献，全部为综述。基于现有文献，除山东、广东、云南三省外，其他省(区、市)尚未报道地区性收费标准。这三个省的PIVAS成本测算方法大致相同，将业务费、劳务费、医疗仪器等购置及使用费、间接费相加即得到成本。PIVAS收费标准为普通药物配置费3～5元/份、抗生素配置费5元/份、肿瘤化疗药配置费8～12元/份，全肠道外营养液配置费20～35元/份，收费水平主要受到当地物价、PIVAS规模、硬件设施投入、管理情况等因素的影响。结论：我国多数省(区、市)PIVAS收费标准尚未建立，且收费标准不统一;纳入的文献中医院的成本测算方法大体一致。有必要构建PIVAS收费的国家标准和成本测算方法，为国家制订医疗卫生服务价格提供依据。
关键词 静脉用药集中调配中心;收费现状;成本测算;收费标准;影响因素
Systematic Evaluation of Current Status of Charges in PIVAS of China
YANG Chunsong1，2，ZHANG Tianyi3，ZHANG Lingli1，2，LIN Yunzhu1，2，HAN Lu1，2，WANG Yeli1，2，GAO Shan1，2，JING Wenrong1，2(1.Dept. of Pharmacy/Evidence-based Pharmacy Center， West China Second University Hospital， Sichuan University， Chengdu 610041， China;2.Key Laboratory of Birth Defects and Related Diseases of Women and Children， Sichuan University， Ministry of Education， Chengdu 610041， China;3.West China School of Pharmacy， Sichuan University， Chengdu 610041， China)
ABSTRACT OBJECTIVE： To systematically evaluate current status of charges in pharmacy intravenous admixture services (PIVAS)， and to provide reference for the formulation of China’s pharmacy intravenous admixture services (PIVAS) charging standards. METHODS： Retrieved from PubMed， Embase， Cochrane library， CBM， CNKI， VIP， Wanfang database and related goverment websets， the literatures about current status evaluation of charges in PIVAS of China were collected during the establishment of database to Jan. 2019. Cost estimation， charge standard， influential factors and other indicators were collected， and the results were presented by descriptive analysis. RESULTS： A total of 5 literatures were included， all of which were reviewed. According to the existing literatures， except for Shandong， Guangdong and Yunnan provinces， there were no regional charge standards in other provinces (districts and cities). The cost estimation methods of PIVAS in these three provinces were basically the same. The cost could be obtained by adding up the business fees， labor fees， fees of medical instruments purchase and use， indirect fees etc. Dispensing charges in PIVAS were 3-5 yuan per piece for general drug， 5 yuan per piece for antibiotics and 8-12 yuan per piece for cancer chemotherapeutics， 20-35 yuan per piece for TPN. The charging level was mainly affected by local prices， PIVAS scale， hardware investment， management and other factors. CONCLUSIONS： There is no unified charging standard for PIVAS in most provinces (districts， cities) of China. The cost estimation methods of the hospitals from the included literatures are basically the same. It is necessary to construct national PIVAS charging standard and cost estimation method， which could provide a basis for formulating the price of medical and health services., http://www.100md.com(杨春松 张天一 张伶俐 林芸竹 韩璐 王叶立 高山 荆文荣)
DOI 10.6039/j.issn.1001-0408.2019.17.22
摘 要 目的：系统评价我国静脉用药集中调配中心(PIVAS)收费现状，为我国PIVAS收费标准的制订提供参考。方法：计算机检索PubMed、Embase、Cochrane图书馆、中国生物医学文献数据库、中国知网、维普网和万方数据及相关政府网站，收集自建库起至 2019年1月上述数据库及网站收录的评价我国PIVAS收费现状的文献，收集PIVAS收费的成本测算、收费标准、影响因素等指标，并对结果进行描述性分析。结果：共纳入5篇文献，全部为综述。基于现有文献，除山东、广东、云南三省外，其他省(区、市)尚未报道地区性收费标准。这三个省的PIVAS成本测算方法大致相同，将业务费、劳务费、医疗仪器等购置及使用费、间接费相加即得到成本。PIVAS收费标准为普通药物配置费3～5元/份、抗生素配置费5元/份、肿瘤化疗药配置费8～12元/份，全肠道外营养液配置费20～35元/份，收费水平主要受到当地物价、PIVAS规模、硬件设施投入、管理情况等因素的影响。结论：我国多数省(区、市)PIVAS收费标准尚未建立，且收费标准不统一;纳入的文献中医院的成本测算方法大体一致。有必要构建PIVAS收费的国家标准和成本测算方法，为国家制订医疗卫生服务价格提供依据。
关键词 静脉用药集中调配中心;收费现状;成本测算;收费标准;影响因素
Systematic Evaluation of Current Status of Charges in PIVAS of China
YANG Chunsong1，2，ZHANG Tianyi3，ZHANG Lingli1，2，LIN Yunzhu1，2，HAN Lu1，2，WANG Yeli1，2，GAO Shan1，2，JING Wenrong1，2(1.Dept. of Pharmacy/Evidence-based Pharmacy Center， West China Second University Hospital， Sichuan University， Chengdu 610041， China;2.Key Laboratory of Birth Defects and Related Diseases of Women and Children， Sichuan University， Ministry of Education， Chengdu 610041， China;3.West China School of Pharmacy， Sichuan University， Chengdu 610041， China)
ABSTRACT OBJECTIVE： To systematically evaluate current status of charges in pharmacy intravenous admixture services (PIVAS)， and to provide reference for the formulation of China’s pharmacy intravenous admixture services (PIVAS) charging standards. METHODS： Retrieved from PubMed， Embase， Cochrane library， CBM， CNKI， VIP， Wanfang database and related goverment websets， the literatures about current status evaluation of charges in PIVAS of China were collected during the establishment of database to Jan. 2019. Cost estimation， charge standard， influential factors and other indicators were collected， and the results were presented by descriptive analysis. RESULTS： A total of 5 literatures were included， all of which were reviewed. According to the existing literatures， except for Shandong， Guangdong and Yunnan provinces， there were no regional charge standards in other provinces (districts and cities). The cost estimation methods of PIVAS in these three provinces were basically the same. The cost could be obtained by adding up the business fees， labor fees， fees of medical instruments purchase and use， indirect fees etc. Dispensing charges in PIVAS were 3-5 yuan per piece for general drug， 5 yuan per piece for antibiotics and 8-12 yuan per piece for cancer chemotherapeutics， 20-35 yuan per piece for TPN. The charging level was mainly affected by local prices， PIVAS scale， hardware investment， management and other factors. CONCLUSIONS： There is no unified charging standard for PIVAS in most provinces (districts， cities) of China. The cost estimation methods of the hospitals from the included literatures are basically the same. It is necessary to construct national PIVAS charging standard and cost estimation method， which could provide a basis for formulating the price of medical and health services., http://www.100md.com(杨春松 张天一 张伶俐 林芸竹 韩璐 王叶立 高山 荆文荣)